Determination of saquinavir in human plasma by high-performance liquid chromatography

Journal of Chromatography B: Biomedical Applications

Volumn 694, Issue 2, 1997, Pages 427-433

  Ha, Huy Riem ^a   Follath, Ferenc ^a   Bloemhard, Yvonne ^a   Krähenbühl, Stephan ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Saquinavir

Indexed keywords

PROTEINASE INHIBITOR; SAQUINAVIR;

ACCURACY; ARTICLE; BIOAVAILABILITY; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STEREOISOMERISM; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

ADMINISTRATION, ORAL; ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HIV PROTEASE INHIBITORS; HUMANS; INJECTIONS, INTRAVENOUS; REPRODUCIBILITY OF RESULTS; SAQUINAVIR;

EID: 0030745207     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(97)00165-5     Document Type: Article

References (6)

1. Noble S., Faulds D. Drugs. 52:1996;93.
2. Vella S. AIDS. 9:1995;S21.
3. Williams P.E.O., Muirhead G.J., Madigan M.J., Mitchell A.M., Shaw T. Br. J. Clin. Pharmacol. 34:1992;155P.
4. Farrar G., Mitchell A.M., Hooper H., Steward F., Malcolm S.L. Br. J. Clin. Pharmacol. 38:1994;162P.
5. Knebel N.G., Sharp S.R., Madigan M.J. J. Mass. Spectrom. 30:1995;1149.
6. S.L. Malcolm, A.F. Clarke, A. James, A. Hutchings and S.M. Coles, Internal Roche Research Report No. 9 (1990).